MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. achieved a net profit attributable to the parent company of 4.98 billion yuan in 2024, an increase of 1.1% year-on-year.

27/02/2025

GMT Eight

MICROPORT(00853) announced the performance of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. for the 12 months ending on December 31, 2024. The revenue was 1.206 billion yuan, an increase of 1.6% compared to the previous year. The net profit attributable to the equity holders of Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. was 498 million yuan, an increase of 1.1% compared to the previous year.

SOLARTECH INT'L (01166) announced its interim performance, with a net loss attributable to shareholders of 26.226 million Hong Kong dollars, a year-on-year decrease of 55.4%.

DeepSeek unlocks the future of edge AI, with Qualcomm (QCOM.US) SoC chips leading the demand dividend.

Contact: contact@gmteight.com

MICROPORT (00853): Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. achieved a net profit attributable to the parent company of 4.98 billion yuan in 2024, an increase of 1.1% year-on-year.

RECOMMEND

US Stock Market Move | Q4 performance below expectations, FirstEnergy Corp. (FE.US) drops more than 8%

CH BIOTECH SER (08037): Hubei Weiyu intends to invest up to 50 million yuan in Pengbo (Hainan).

US Stock Market Move | Reports say that the US government is considering withdrawing funding for the company's avian flu vaccine. Moderna (MRNA.US) fell more than 6%.